Key facts
- This page summarizes Shalom Auerbach's Form 4 filing for OS Therapies Inc (OSTX).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 09 May 2025, 21:30.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Sale
No transaction description listed
Additional SEC filing notes
Footnote F1
The shares of common stock, par value $0.001 per share (the "Common Stock"), of the Issuer are held directly by Einodmil LLC ("Einodmil"). Mr. Auerbach serves as the Principal of Einodmil and exercises voting and dispositive power over the shares held by Einodmil. Mr. Auerbach disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.
Footnote F2
The price reported in Column 4 is a weighted average price. These shares of Comm Stock were sold in multiple transactions at prices ranging from $1.69 to $2.22 per share, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.